Mrs. Cecelia Corley, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 N. School St., Poyen, AR 72128 Phone: 501-332-2939 Fax: 501-332-7800 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
An international research team, led by scientists from Mater Research - The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows cell growth.
Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation, is pleased to highlight a study recently authored by Martin Skov Neergaard from the Faculty of Health and Medical Sciences at the University of Copenhagen, "Protein-Protein Interactions Investigated by DLS: Determination at High and Low Protein Concentration."
A Jordanian study was conducted to investigate the effects of the COVID-19 national lockdown on stillbirth, neonatal-perinatal mortality, preterm birth, and birth weight.
Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.
› Verified 3 days ago